| Patent Number |
AU2006261133 A1 2006-12-28 |
|
Therapeutic peptides and vaccines
|
Compositions are disclosed that induce broadly HIV theraputic and vaccine inducing antibodies against diverse HIV clades and relate to the ability to identify HIV gpl20-derived short peptide sequence immunogens and various therapeutic compositions made from the identified peptides which compose CCR5 binding sites.Also disclosed are methods of selecting peptide sequences that are likely candidates for drugs which will offer effective treatment in such areas as Alzheimer's disease, psoriasis, multiple sclerosis and other diseases associated with the human inflammatory cascade as well as related retroviruses such as HTLV-I, the cause of tropical spastic paraparesis.
|
©Questel
|
|
| FamPat family |
| Publication Number |
Type |
Publi.Date |
Links |
 |
EP1893233 |
A2 |
2008-03-05 |
  |
|
STG: |
(A2) Application published without search report |
|
AP: |
2006EP-0785485 |
| |
EP1893233 |
A4 |
2010-03-31 |
|
|
STG: |
(A4) Supplementary search report |
|
AP: |
2006EP-0785485 |
 |
US20060292167 |
A1 |
2006-12-28 |
|
|
STG: |
(A1) Application published |
|
AP: |
2006US-11426301 |
| |
US7700115 |
B2 |
2010-04-20 |
|
|
STG: |
(B2) Granted patent as second publication |
|
AP: |
2006US-11426301 |
| |
US20100184705 |
A1 |
2010-07-22 |
|
|
STG: |
(A1) Application published |
|
AP: |
2010US-12688862 |
| |
US10071153 |
B2 |
2018-09-11 |
|
|
STG: |
(B2) Granted patent as second publication |
|
AP: |
2010US-12688862 |
| |
US20190000964 |
A1 |
2019-01-03 |
|
|
STG: |
(A1) Application published |
|
AP: |
2018US-16054455 |
| |
US10973906 |
B2 |
2021-04-13 |
|
|
STG: |
(B2) Granted patent as second publication |
|
AP: |
2018US-16054455 |
| PCT |
WO2006/138745 |
A2 |
2006-12-28 |
|
|
STG: |
(A2) International application published without international search report |
|
AP: |
2006WO-US24580 |
| PCT |
WO2006/138745 |
A3 |
2007-11-29 |
|
|
STG: |
(A3) Later publication of ISR with revised front page |
|
AP: |
2006WO-US24580 |
 |
JP2008546803 |
A |
2008-12-25 |
|
|
STG: |
(A) Published application |
|
AP: |
2008JP-0518460 |
 |
CA2624957 |
A1 |
2006-12-28 |
|
|
STG: |
(A1) Application laid open |
|
AP: |
2006CA-2624957 |
 |
KR10-2008-0019720 |
A |
2008-03-04 |
|
|
STG: |
(A) Published application |
|
AP: |
2008KR-7001808 |
 |
CN101242854 |
A |
2008-08-13 |
|
|
STG: |
(A) Published application |
|
AP: |
2006CN-80030505 |
 |
BRPI0611927 |
A2 |
2011-08-16 |
|
|
STG: |
(A2) Application for a patent of invention / pipeline patent published without search report |
|
AP: |
2006BR-0011927 |
 |
AU2006261133 |
A1 |
2006-12-28 |
|
|
STG: |
(A1) Open to public inspection |
|
AP: |
2006AU-0261133 |
| |
AU2006261133 |
B2 |
2012-04-05 |
|
|
STG: |
(B2) Patent proceeded by OPI |
|
AP: |
2006AU-0261133 |
 |
IN2183/MUMNP/2007 |
A |
2008-02-01 |
|
|
STG: |
(A) Application laid open |
|
AP: |
2007IN-MN02183 |
| |
IN250447 |
B |
2012-01-06 |
|
|
STG: |
(B) Patent |
|
AP: |
2007IN-MN02183 |
 |
MX2007016573 |
A |
2008-10-17 |
|
|
STG: |
(A) Patent application |
|
AP: |
2007MX-PA16573 |
| |
MX301305 |
B |
2012-07-13 |
|
|
STG: |
(B) Granted patent/ granted utility model |
|
AP: |
2007MX-PA16573 |
 |
ZA200800566 |
B |
2008-11-26 |
|
|
STG: |
(B) Granted Patent |
|
AP: |
2008ZA-0000566 |
|
| First Date of Grant |
2010-04-20 |
|
2018-09-11 |
|
2021-04-13 |
|
2008-11-26 |
|
2012-01-06 |
|
2012-04-05 |
|
2012-07-13 |
| Inventor |
CANDACE PERT
MICHAEL RUFF |
| All applicant/assignee |
RAPID Pharmaceuticals, AG ([CH])
RAPID Pharmaceuticals, AG ([CH]) |
|
RUFF MICHAEL
PERT CANDACE
Rapid Pharmaceuticals AG ([CH]) |
|
RUFF MICHAEL
PERT CANDACE
Ruff Michael ([US])
Pert Candace ([US]) |
|
Creative Bio-Peptides Inc. ([US])
Creative Bio-Peptides Inc. ([US]) |
|
PERT, Candace ([US])
RUFF, Michael ([US])
PERT, CANDACE
RUFF, MICHAEL |
|
Rapid Pharmaceuticals Inc |
|
RAPID PHARMACEUTICALS INC. |
|
RAPID PHARMACEUTICALS AG. |
|
RAPID PHARMACEUTICALS INC ([US])
RAPID PHARMACEUTICALS AG |
|
MICHAEL RUFF
CANDACE PERT
Rapid Pharmaceuticals AG |
|
RAPID PHARMACEUTICALS INC. ([US]) |
|
RAPID PHARMACEUTICALS INC. |
|
RAPID PHARMACEUTICALS, AG. |
|
RAPID PHARMACEUTICALS INC.
RAPID PHARMACEUTICALS INC |
| Priority Details |
2005US-60693087 2005-06-232005US-60693088 2005-06-232005US-60693089 2005-06-232006US-11426301 2006-06-232006WO-US24580 2006-06-232010US-12688862 2010-01-162018US-16054455 2018-08-03 |
| Designated States |
Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
National States: AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HN HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LA LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RS RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ MD RU TJ TM
EPO: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
| |
|
©Questel
|